Aging Clinical Trial
— NUTRIAGINGPROTOfficial title:
Effects of Low or High Amounts of Dietary Protein and Resistance Training on Community-dwelling Older Adults: a Randomized Controlled Trial
Verified date | July 2019 |
Source | University of Vienna |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this randomized, observer-blind, controlled intervention study with parallel
groups is to study the effect of resistance training (2x/week for 8 weeks) with and without
different goals of protein intake on muscle strength, function and mass, oxidative stress
parameters and the immune system in community dwelling persons.
Participants (n = 137) will be community-dwelling older adults. After a pre-participation
screening participants will be distributed randomly but stratified by sex and age to one of
the 3 groups (low protein + strength training, high protein + strength training, low protein
and no strength training(=control)). Study participants are eligible if they are male or
female with an age between 65 and 85 years and if their cognitive status as well as their
physical fitness level allows to participate at the strength training sessions. Exclusion
criteria comprise chronic diseases which contraindicate the training sessions, serious
cardiovascular disease, diabetic retinopathy and manifest osteoporosis, a frailty index at or
above 3, medication with anticoagulants or cortisone drugs and also regular strength training
during the last six months.
Primary outcome measure is the change in the Chair Stand Test. Secondary outcome measures
comprise anthropometric data, functional performance tests, immunological and oxidative
stress parameters, microbiota, metabolomics, proteomics and the nutritional status.
Status | Active, not recruiting |
Enrollment | 137 |
Est. completion date | January 1, 2021 |
Est. primary completion date | February 28, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 65 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Males and females between the age of 65 and 85 years of age - Adequate mental condition in order to follow the instructions and to perform the resistance exercise independently (Mini-Mental-State >23) - Independently mobile Exclusion Criteria: - Chronic diseases, which contraindicate a training participation - Serious cardiovascular diseases (congestive chronic heart failure, severe or symptomatic aortic stenosis, unstable angina pectoris, untreated arterial hypertension, cardiac arrhythmias) - Diabetic retinopathy - Manifest osteoporosis - Regular use of cortisone-containing drugs - Regular strength training (> 1x / week) in the last 6 months before inclusion |
Country | Name | City | State |
---|---|---|---|
Austria | University of Vienna, Department of Nutritional Sciences | Vienna |
Lead Sponsor | Collaborator |
---|---|
University of Vienna |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in chair stand test (repetitions) | The maximum number of completed cycles of unsupported chair rises (from a seated to a fully erected position (hip and knees straightened)) completed within 30 s is counted. | baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks) | |
Secondary | Change from baseline in isometric quadriceps peak torque (Nm/kg) | Isokinetic peak torque measurements of knee extensors and flexors will be performed using a LIDO Multijoint II isokinetic loading dynamometer. Participants will be tested in a sitting posion with their hip flexed at approximately 90° and subjects securely strapped to the seat of the chair using adjustable trunk and waist stabilisation belts. The anatomic axis of the knee rotation at the knee joint will aligned with the machine axis of rotation to insure similar movements for all participants. Two continuous maximal repetitions of knee extensors and knee flexors will be performed concentrically at each angular velocity (60°/s and 120°/s) for peak torque recording. | baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks) | |
Secondary | Change from baseline in handgrip strength (kg) | Handgrip strength of the right hand will be measured to the nearest kilogram (kg) using a hand Dynamometer. Participants will be encouraged to perform a maximal contraction within approximately 4 to 5 s. After a rest of 60 s, participants will be asked to perform a second trial. The highest score of maximum voluntary contraction will be used for data analyses. | baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks) | |
Secondary | Change from baseline in muscle mass with BIA (kg) | baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks) | ||
Secondary | Change from baseline in 6min walking test (distance in meter) | baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks) | ||
Secondary | Change from baseline in the composition of gut-microbiota | Gene sequencing of the 16S rRNA on the stool samples are performed to identify the microbes down to genus level, as well as the microbrobiota diversity and relative abundance. | baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks) | |
Secondary | Change from baseline in stool short-chain fatty acids (SCFAs) | The stool short-chain fatty acids (SCFAs) will be extracted and quantitatively analysed by gas chromatography. | baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks) | |
Secondary | Change from baseline in oxidative stress marker such as malondialdehyd | The investigators will consider changes in plasma concentrations of oxidative stress marker such as malondialdehyde from baseline to the end of the intervention. | baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks) | |
Secondary | Change from baseline in inflammatory marker (i.g. IL-6, TNF-alpha) | The investigators will consider changes in plasma concentrations of Interleukin 1 (IL-1), IL-6, IL-8, IL-10, TNF-alpha | baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks) | |
Secondary | Change from baseline in the metabolomics response | The metabolomic response (ie all metabolites) to the interventions will be analyzed using both nuclear magnetic resonance (NMR) and mass spectrometry (MS) techniques. Patterns of metabolites will be evaluated with statistical techniques, ie discriminant analysis and principal component analysis. | baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks) | |
Secondary | Change from baseline in the amino acid pattern | The plasma amino acid pattern will be assessed with HPLC-MS. | baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Recruiting |
NCT06032065 -
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD)
|
Phase 3 | |
Completed |
NCT05293730 -
Trial of the Impact of the Electronic Frailty Integrated With Social Needs
|
N/A | |
Recruiting |
NCT03932162 -
Gene Expression Changes In Young and Geriatric Skin
|
Early Phase 1 | |
Completed |
NCT04064528 -
Effects of Age on Amino Acid Delivery to Tendon
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT06029920 -
Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT05566938 -
Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly
|
N/A | |
Recruiting |
NCT05543980 -
Leg Heat Therapy in Elderly Individuals
|
Phase 2 | |
Completed |
NCT04894929 -
Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement
|
N/A | |
Not yet recruiting |
NCT06071130 -
Emotion, Aging, and Decision Making
|
N/A | |
Enrolling by invitation |
NCT04641663 -
Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST)
|
N/A | |
Completed |
NCT04088006 -
The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity
|
N/A | |
Completed |
NCT03695081 -
Patient Pathway Pharmacist - Optimal Drug-related Care
|
N/A | |
Recruiting |
NCT05424263 -
Acetate and Age-associated Arterial Dysfunction
|
Phase 2 | |
Completed |
NCT05601713 -
Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling
|
N/A | |
Completed |
NCT04551339 -
Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19
|
N/A | |
Recruiting |
NCT04997577 -
Speech Perception and High Cognitive Demand
|
N/A | |
Completed |
NCT05922475 -
Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training
|
N/A | |
Completed |
NCT04015479 -
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults
|
N/A |